Latrobe Magnesium Limited Overview
Latrobe Magnesium is an Australian development-stage producer of primary magnesium metal. It uses a patented hydrometallurgical-plus-thermal-reduction process that converts industrial waste into magnesium and saleable co-products: brown-coal fly ash in Victoria, and ferronickel slag for its larger proposed plants. Its 1,000tpa-nameplate Demonstration Plant at Hazelwood North has run the hydrometallurgical stage (Stage 1A) and produced sustained high-grade magnesium oxide. The pyrometallurgical stage (Phase 1B) was about 90% installed in October 2026, with first >98% magnesium crowns targeted from a November–December 2026 campaign. All demonstration-plant metal is sold to US distributor Metal Exchange LLC. Primary magnesium supply is more than 90% Chinese, and the only US primary producer (US Magnesium) entered Chapter 11 in September 2025. Against that backdrop, LMG's strategy turned in September 2026 toward a proposed 50ktpa, US$1.1–1.5 billion plant in South Carolina. A 100ktpa Malaysian project sits behind it, and the 10ktpa Victorian commercial plant is paused. Funding remains the dominant constraint.
What the company does. LMG is building the industrial capability to produce primary magnesium metal outside China from waste feedstocks. Its process has two stages:
-
Hydrometallurgical extraction ("Hydromet"): Magnesium-rich waste is leached and processed through a spray roaster to produce magnesium oxide (MgO). In Victoria the feed is fly ash from the Yallourn brown-coal power station; overseas it would be ferronickel slag. The by-products include supplementary cementitious material (SCM), amorphous silica, char and iron oxide.
-
Thermal (silicothermic-type) reduction ("Pyromet"): MgO is briquetted and reduced in retorts or furnaces to magnesium vapour, which is condensed into magnesium "crowns" and then refined into ingot or alloy.
The company describes itself in 2026 ASX announcements as developing a magnesium metal Demonstration Plant in Victoria's Latrobe Valley using a world-first patented extraction process, producing magnesium metal, cementitious material and other products from industrial ash, a waste stream of brown-coal power generation. Following the September 2026 strategic pivot, its boilerplate now calls it "a magnesium metal developer with projects in Australia, the United States and Malaysia."
Business model and revenue model. LMG intends to be a product seller of commodity and specialty metal. There are no services, subscriptions or licensing revenue streams, although the patented process could in principle be licensed; no licensing arrangement has been disclosed. Revenue to date is negligible:
-
small early MgO sales, including to Western Australian dust-suppression specialist Rainstorm Dust Control (per SmallCaps, 2024);
-
interest income;
-
R&D tax incentive income, which is largely capitalised or deferred against plant.
The planned revenue mix is magnesium metal (the dominant share) plus co-products: SCM for cement and concrete, silica, and iron oxide. For the US project, the company has explicitly included silica (SiO2) at US$500–750/t in its economics.
Value chain position. LMG is upstream and primary. It converts waste feedstock into primary metal and alloy, and sells into the US through a distributor (Metal Exchange LLC) rather than directly to end-users at demonstration scale. For the proposed US plant, it has letters of intent (LOIs) with end-users covering 32ktpa.
Customer types and end-markets.
Independent characterisation. LMG is a single-asset technology-validation company whose valuation rests almost entirely on optionality: that the process scales, and that Western governments and consumers will pay a security-of-supply premium over Chinese magnesium. The core economic argument is the price arbitrage in its own disclosures. FOB China magnesium traded around US$2,300–2,800/t in FY2025–FY2026, while US delivered prices sat around US$7,000/t (US$7,050/t cited on 15 September 2026; US$7,165/t in the April 2026 presentation), helped by US anti-dumping duties and the absence of US tariffs on Australian magnesium.
The company has a long record of schedule slippage. The commercial plant was once targeted for December 2025, then the first half of 2026, then the first half of 2028, and is now paused. Demonstration metal production has slipped from "late 2023" to late 2026. Its funding base has relied on R&D tax rebates, small equity raises at falling prices, and a structured placement facility. The September 2026 US pivot greatly enlarges the opportunity, but it also enlarges the execution and financing gap relative to a ~A$50M market capitalisation.
Strategy
Stated strategy (themes from 2025–2026 annual report and investor materials):
-
Prove the technology at demonstration scale. Complete Phase 1B and produce >98% Mg crowns, establishing LMG as among the most advanced independent primary magnesium developments outside China (Stein, 8 Sep 2026).
-
Become a secure Western source of primary magnesium. Position against Chinese concentration (>90–95% of supply) and the collapse of US domestic production.
-
Waste-to-value circular economy. Recycle power-station fly ash and ferronickel slag, avoiding landfill and cutting CO2 relative to the Chinese Pidgeon process.
-
Scale through staged plants. The sequencing has changed:
-
Prior: Stage 2 (10ktpa, Victoria) → Stage 3 (100ktpa, Malaysia).
-
Current (Sept 2026): the US 50ktpa plant is prioritised, Malaysia continues, and Victoria Stage 2 is paused.
-
-
Contracted offtake and non-dilutive funding. Examples: the MX prepayment, EFA and US EXIM letters of support, South Carolina incentives, and the US$15M FS letter of support.
ESG commitments. Projects are framed as exemplifying circular-economy practice, recycling power-plant waste tailings and avoiding landfill. Formal emissions targets and science-based targets are not publicly disclosed.
Cost programmes. No formal cost-out programme. Phase 1B is managed to its original A$6.1M budget (October 2026 update).
Products & Services
All products sit within the single segment. Commercial volumes are not yet established.
Flagship offering: the patented Hydromet extraction process and the resulting low-emission primary magnesium metal. The company has cited CO2 emissions about 60% below the industry average (SmallCaps, 2024), and some trade press describes the process as net-zero.
Product Portfolio
| Product | Description & specifications | Target customer | Status / year | Pricing |
|---|---|---|---|---|
Magnesium oxide (MgO) | High-grade MgO from fly ash via Hydromet; ~20t produced over two weeks in Feb 2026, with XRD assays confirming suitability for metal production; earlier trial batches >80% purity (2024) | Internal feed to Phase 1B; early external sales (e.g., Rainstorm Dust Control, dust suppression) | First produced 2024; sustained production 2026 | — |
Magnesium crowns (>98% Mg) | Condensed Mg from thermal reduction; the first demo-plant metal product | Metal Exchange LLC (100% offtake) | Targeted from Nov–Dec 2026 campaign | MX framework with floor price and margin sharing; US$2M prepayment |
Refined magnesium ingot (99.8–99.9%) | Refined primary metal | US aluminium, automotive, defence buyers via MX; LOI customers for the US plant | Commercial-scale planned (Victoria paused; US 2030) | Realised price assumption US$5,000–7,500/t (US plant economics) |
Magnesium alloys (casting & extrusion) | Alloyed product from the US plant | Die-casters, extruders, aerospace/defence | US project scope (2030+) | — |
Supplementary cementitious material (SCM) | Cement-replacement co-product of Hydromet | Cement/concrete producers | Demonstrated at demo scale | — |
Amorphous silica (SiO2) | Co-product | Industrial users | US plant assumes US$500–750/t | US$500–750/t (assumption) |
Char, iron oxide | Minor co-products from fly-ash processing | Industrial | Demo-scale | — |
Technology/IP | Patented Hydromet extraction plus thermal reduction process | Potential licensees (none disclosed) | Patented (patent family size not disclosed) | No licensing revenue |
“—” = not publicly disclosed.
Financial Narrative
Source for all tables: S&P Global Market Intelligence standardised financials (via StockAnalysis.com, updated 24 Sep 2026), derived from LMG annual reports FY2022–FY2026. AUD millions unless stated. Ratios computed by the analyst from these figures, on year-end balances.
Income statement
Notes: - Gross profit is shown as zero because no cost-of-sales line is separately reported. The company is pre-commercial.
-
EPS is computed by the analyst as net income divided by weighted shares; S&P displays −0.00 due to rounding.
-
FY2024 tax expense of A$5.41M (an 812% effective rate) reflects deferred tax accounting related to R&D offsets and was the main reason the H1 FY2025 loss later narrowed ("reduction in income tax expense", HY Dec-2024 report).
-
H1 FY2026 statutory loss was A$2,541,560 versus A$1,844,730 in H1 FY2025 (HY Dec-2025 report). Full-year FY2026 net loss was A$4.87M.
Margins. Gross, operating, EBITDA and net margins are not meaningful: denominators are near-zero non-product income, and margins computed on "revenue as reported" would range from roughly −290% to +9%. Revenue CAGR (FY2022–FY2026) on reported income is +5.5%, but this is not meaningful as a growth measure.
Commentary. The P&L is a cost-centre profile. SG&A rose from A$3.4M (FY2023) to A$5.9M (FY2026) as management expanded ahead of production; the company attributed the H1 FY2024 loss spike to costs of expanding the management team. Most project expenditure is capitalised into property, plant and equipment, which grew from A$11.6M to A$97.1M over five years. As a result, reported losses (A$2–5M p.a.) understate cash consumption. The FY2026 loss of A$4.87M was the largest in five years. It reflected higher overheads during MgO operations and Phase 1B, a lower recognised other income of A$1.67M, and the leadership transition. The FY2024 operating profit of A$0.59M was an accounting artefact of A$6.3M of "other operating income" recognition, not commercial earnings.
Balance sheet
Notes: - Net debt is shown positive when debt exceeds cash. FY2022 was a net cash position of A$9.66M.
-
The "current portion of leases" line (A$13.64M in FY2026) is S&P's classification. In LMG's statutory accounts the bulk of current borrowings has historically been the R&D-rebate-backed project finance facility (A$28M limit; lender RnD Funding), repaid as rebates are received. Classification of the FY2026 balance between facility debt and leases should be confirmed against the statutory note.
-
"Long-term unearned revenue" (A$40.7M) is S&P's label for long-term deferred income. Analyst interpretation: this most likely reflects R&D tax incentive and government grants deferred against capitalised plant under AASB 120. This should be confirmed in the statutory notes; it is not a customer liability in the conventional sense.
Commentary. The balance sheet has expanded into a plant-heavy, liquidity-poor structure. PP&E is 81% of total assets, cash was only A$1.09M at 30 June 2026, and working capital was −A$3.66M. Liquidity depends on three things:
The R&D rebate cycle: FY2026 receivables of A$13.06M likely include the accrued FY2026 R&D refundable offset. The company noted in December 2025 that it had already generated a 2026 rebate from expenditure in the first four months of FY2026.
The Long State facility: - The September 2026 A$8.5M equity raise.
Total debt more than doubled in FY2026 to A$17.0M as the facility was redrawn ahead of the next rebate. Equity has grown only through issuance: contributed capital rose from A$48.5M to A$96.0M while accumulated losses deepened to −A$47.7M. There is no goodwill; intangibles of ~A$7M represent capitalised patent and technology costs.
Cash flow
Commentary. Operating cash flow turned positive in FY2024–FY2026 only because R&D refundable offsets are received as operating cash: A$12.9M in May 2024, A$13.24M in late 2024, and A$6.29M in December 2025. Excluding rebates, underlying operating cash burn is roughly A$4–6M p.a. Capex peaked at A$27.3M in FY2024 during demo-plant construction, then fell to A$6–9M as construction slowed and Phase 1B was rescoped to an A$6.1M budget. Quarterly data illustrate the volatility. The December 2025 quarter showed +A$4.41M operating cash flow (rebate receipt) and cash of A$4.52M. The June 2026 quarter showed −A$0.89M operating cash flow and cash of A$1.09M.
Ratios
Not meaningful / not computable: net debt/EBITDA (EBITDA negative in four of five years; FNArena shows debt/EBITDA of −1.51); interest coverage (EBIT negative except FY2024, when EBIT/interest was ~2.8x); cash conversion cycle (no trading revenue or inventory cycle).
Trend synthesis. The financial trajectory shows capitalised construction, rebate-dependent liquidity and serial dilution: weighted shares nearly doubled from 1,490M to 2,962M in four years, a share-count CAGR of ~19%. The key inflection will be the first metal sales to Metal Exchange (FY2027), but demo-scale volumes will not change the earnings profile. Value creation depends on financing a commercial plant (US or Malaysia).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Jurisdiction | Role |
|---|---|---|
Latrobe Magnesium Limited | Australia | Listed parent; owns the Victorian Demonstration Plant and IP |
Latrobe Magnesium Sarawak Sdn Bhd (LMS) | Malaysia | 100% subsidiary for the Stage 3 100ktpa International Plant |
US subsidiary (name not disclosed in sources reviewed) | USA | Vehicle for the 50ktpa South Carolina project and feasibility study (referenced in 17 Sep 2026 announcement) |
Stage Details
| Stage | Asset | Capacity | Feedstock | Status (Oct 2026) |
|---|---|---|---|---|
Stage 1A | Demonstration Plant: hydromet/MgO section, Hazelwood North VIC | ~1,000tpa nameplate (metal-equivalent design); described as a 500tpa magnesium plant in the Oct 2025 raise | Yallourn brown-coal fly ash | Complete; sustained MgO campaigns achieved Feb 2026 |
Stage 1B / Phase 1B | Demonstration Plant: pyromet/metal section | Demo scale | MgO from Stage 1A | ~90% installed (1 Oct 2026); 4-week campaign targeted Nov–Dec 2026 |
Stage 2 | Commercial Plant, Latrobe Valley VIC | 10,000tpa Mg | Fly ash | Paused (legislative issues, Jun-2026 qtr); previously targeted 1H CY2028 |
Stage 3 | International Plant, Sarawak, Malaysia | 100,000tpa Mg | Ferronickel slag | Pre-feasibility; land, permitting and power access reported as secured (Jul 2026) |
US Project | South Carolina, USA | 50ktpa (Train 1), expandable to 100ktpa | Ferronickel slag (SLN/Eramet) | Feasibility study stage; first production targeted April 2030 |
Results by Segment and Revenue by Segment (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Single segment revenue as reported (AUD Mn) | 1.35 | 1.94 | 6.58 | 2.73 | 1.67 |
Single segment operating income (AUD Mn) | -3.19 | -2.5 | 0.59 | -2.51 | -4.27 |
Single segment pre-tax income (AUD Mn) | -3.21 | -2.44 | 0.67 | -2.84 | -4.44 |
Contribution to total revenue (%) | 100 | 100 | 100 | 100 | 100 |
Income Statement and Share Count (M)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue as reported incl. other income (AUD Mn) | 1.35 | 1.94 | 6.58 | 2.73 | 1.67 |
Gross profit (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
SG&A (AUD Mn) | 3.67 | 3.36 | 5.35 | 5.12 | 5.92 |
R&D expensed (AUD Mn) | 0.85 | 1.01 | 0.37 | 0.09 | 0.03 |
Operating income EBIT (AUD Mn) | -3.19 | -2.5 | 0.59 | -2.51 | -4.27 |
EBITDA (AUD Mn) | -3.18 | -2.49 | 0.61 | -2.49 | -4.24 |
Interest expense (AUD Mn) | -0.03 | 0 | -0.21 | -0.36 | -0.16 |
Pre-tax income (AUD Mn) | -3.21 | -2.44 | 0.67 | -2.84 | -4.44 |
Income tax expense (AUD Mn) | 0 | 0 | 5.41 | -0.18 | 0.43 |
Net income (AUD Mn) | -3.21 | -2.44 | -4.74 | -2.66 | -4.87 |
Weighted avg shares basic (M) | 1,490 | 1,627 | 1,851 | 2,395 | 2,962 |
EPS basic and diluted (AUD cents) | -0.22 | -0.15 | -0.26 | -0.11 | -0.16 |
Dividends per share (AUD) | 0 | 0 | 0 | 0 | 0 |
Balance Sheet and Share Count (M)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (AUD Mn) | 37.39 | 62.47 | 95.4 | 92.5 | 119.67 |
Cash and equivalents (AUD Mn) | 15.25 | 6.89 | 0.57 | 2.42 | 1.09 |
Receivables incl R&D offsets (AUD Mn) | 3.4 | 13.82 | 16.22 | 6.39 | 13.06 |
Property plant and equipment (AUD Mn) | 11.64 | 34.63 | 71.17 | 75.33 | 97.06 |
Intangibles incl patents (AUD Mn) | 6.92 | 6.95 | 6.99 | 7.03 | 7.08 |
Goodwill (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Short-term debt incl current leases (AUD Mn) | 0.01 | 12.66 | 7.29 | 7.79 | 14.11 |
Long-term debt incl leases (AUD Mn) | 5.58 | 2.71 | 6.56 | 0 | 2.88 |
Total debt (AUD Mn) | 5.59 | 15.37 | 13.86 | 7.79 | 16.99 |
Net debt (AUD Mn) | -9.66 | 8.48 | 13.3 | 5.37 | 15.9 |
Long-term unearned revenue / deferred income (AUD Mn) | 5.48 | 16.56 | 26.67 | 30.55 | 40.71 |
Total liabilities (AUD Mn) | 14.68 | 36.16 | 53.78 | 43.84 | 65.55 |
Shareholders equity (AUD Mn) | 22.71 | 26.31 | 41.63 | 48.67 | 54.13 |
Working capital (AUD Mn) | 15.13 | 3.9 | -0.67 | -0.75 | -3.66 |
Shares outstanding year-end (M) | 1,611 | 1,725 | 2,192 | 2,627 | 3,129 |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Operating cash flow (AUD Mn) | -3.74 | -4.31 | 11.5 | 8.1 | 1.76 |
Capital expenditure (AUD Mn) | 3.36 | 17.25 | 27.31 | 6.17 | 8.99 |
Free cash flow (AUD Mn) | -7.1 | -21.56 | -15.81 | 1.93 | -7.23 |
Dividends paid (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (AUD Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE on year-end equity (%) | -14.1 | -9.3 | -11.4 | -5.5 | -9 |
ROA on year-end assets (%) | -8.6 | -3.9 | -5 | -2.9 | -4.1 |
ROIC approx EBIT over equity plus debt (%) | -11.3 | -6 | 1.1 | -4.5 | -6.0 |
Current ratio (x) | 5.18 | 1.23 | 0.96 | 0.93 | 0.81 |
Debt to equity (x) | 0.25 | 0.58 | 0.33 | 0.16 | 0.31 |
Asset turnover on reported income (x) | 0.04 | 0.03 | 0.07 | 0.03 | 0.01 |
Revenue by Region
| Region | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Australia revenue as reported (AUD Mn) | 6.58 | 2.73 | 1.67 |
Americas revenue (AUD Mn) | 0 | 0 | 0 |
APAC ex-Australia revenue (AUD Mn) | 0 | 0 | 0 |
EMEA revenue (AUD Mn) | 0 | 0 | 0 |
Share Price
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
Share price 30 June close (AUD) | 0.016 | 0.06 | 0.053 | 0.047 | 0.008 | 0.013 |
Share Price History
| Period | Reference price | Change |
|---|---|---|
1-year | ~A$0.027 (last trade before Oct-2025 raise, implied by A$0.023 at a 14.8% discount) | ~−48% |
3-year | ~A$0.04 (52-week low on 2 Oct 2023) | ~−65% |
5-year | ~A$0.016 (30 Jun 2021) | ~−12% |
Valuation Multiples
| Multiple | LMG | Comment |
|---|---|---|
P/E | n/m (loss-making) | — |
EV/EBITDA | n/m (negative EBITDA) | EV ≈ A$48M mkt cap + A$15.9M net debt ≈ A$64M (pre-raise) |
EV/Sales | n/m | — |
P/B | ~0.9x (A$48M / A$54.1M equity) | Below book; StockLight notes P/B below industry average |
P/FCF | n/m (FY2026 FCF −A$7.2M); 10.9x on FY2025 rebate-driven FCF | — |
Capital Instruments
| Instrument | Limit / balance | Maturity |
|---|---|---|
R&D-backed project finance facility (RnD Funding) | A$28M limit; drawn balance fluctuates with rebate cycle (total debt A$17.0M at 30 Jun 2026) | 31 Dec 2027 |
Leases / other | Included in S&P totals | — |
Metal Exchange prepayment | US$2M (recovered via margin share on deliveries) | Through deliveries |
“—” = not publicly disclosed.
Share Price & Returns
| Date | Raise | Price |
|---|---|---|
| 2021 | A$11.5M placement | A$0.10 (115M shares) |
May 2023 | A$4.2M placement | A$0.06 |
Late 2023 | A$3.06M | — |
Oct 2025 | A$10.0M placement + entitlement | A$0.023 |
Jul 2026 | Up to A$16M Long State facility | Structured (swap) |
Sep 2026 | A$8.5M placement + entitlement | A$0.015 |
Analyst Conclusions
Management guidance:
-
First magnesium metal (>98% crowns) from a four-week Phase 1B campaign in November–December 2026, within the A$6.1M budget.
-
First deliveries to Metal Exchange in H2 CY2026.
-
A US 50ktpa feasibility study, funded by the US$15M support letter and the September raise.
-
First US production targeted for April 2030.
-
Malaysia advancing.
-
Victoria Stage 2 paused.
Consensus: none (no analyst coverage).
Bull case
-
Technology de-risking is imminent. Phase 1B is 90% installed and on budget, and the first metal campaign is weeks away. Successful >98% crowns would validate the full patented flowsheet for the first time and transform the credibility of the US and Malaysian projects.
-
Strategic scarcity value. With US Magnesium in Chapter 11 and more than 90% of supply Chinese, a 50ktpa US plant (~30% of US consumption) with secured slag feedstock, 32ktpa of LOIs, state incentives and Bechtel engineering is precisely the type of asset US defence and industrial policy aims to fund.
-
Asymmetric valuation. Indicative US NPV10 of US$1.4–2.7B and EBITDA of US$320–615M p.a. compare with an enterprise value near A$60M and a P/B below 1x. Even heavily risked, the optionality is large.
Bear case
-
Financing chasm. US$1.1–1.5B of capex against cash of A$1.09M at June 2026, a facility maturing December 2027, and serial raises at declining prices (A$0.06 → A$0.023 → A$0.015) imply severe dilution or the loss of project control.
-
Execution record. Every major schedule has slipped by years, and the Hydromet stage suffered equipment defects. The US plant targets 2030 and is unproven at any scale.
-
Strategic drift and overhang. The pause of Victoria Stage 2, three concurrent geographies, a new CEO, Long State's share selldown, and weak 2026 Chinese prices could all erode near-term support.
Analyst verdict. Latrobe Magnesium enters FY2027 at its most consequential juncture in two decades. The founder has handed over to a capital-markets-literate CEO. The demonstration plant stands at the threshold of its first magnesium metal, and the company has re-cast itself from a regional Victorian project into an aspirant North American primary magnesium supplier. The strategic logic is compelling. Western primary magnesium supply has largely collapsed, the US has no operating primary producer, and the US price premium of roughly three times Chinese FOB is structural while trade protection and defence priorities persist. LMG brings real assets to that gap: a patented, demonstrated Hydromet stage, two decades of secured slag feedstock, a committed US distributor that has paid a prepayment, and credible engineering and export-credit relationships.
The financial reality, however, is unforgiving. With A$1.1M of cash at June 2026, negative working capital, a debt facility tied to R&D rebates, and a funding history of progressively cheaper equity, LMG remains a financing-dependent option rather than an investable industrial business. Its record of multi-year slippage argues for heavy discounting of every published timeline, including April 2030 for the US plant. Pivoting toward a US$1.1–1.5B project while the 10ktpa Victorian plant is paused raises the stakes considerably. Success now depends on attracting a strategic, government or sovereign partner on terms that leave meaningful value for existing shareholders.
The near-term investment case is binary and observable. A clean November–December 2026 metal campaign, first shipments to Metal Exchange, and conversion of non-binding US support into binding capital would justify a substantial re-rating from below book value. Failure or further delay would likely force deeply dilutive funding. Verdict: speculative, high-risk, catalyst-driven; suitable only for risk capital, with position sizing anchored on Phase 1B results and the quality of US project financing.
-
Employee numbers and trend
-
ISIN
-
Former corporate names
-
Full FY2026 board composition and committee memberships
-
FY2026 remuneration report figures and Robert Stein's package
-
Top-10 institutional holders
-
Patent family count
-
FY2022 and FY2026 R&D rebate amounts
-
Details of the EPA notices and the Victorian legislative issue
-
Names of US LOI counterparties
-
South Carolina site details
-
Competitor financials
These should be completed from the FY2026 Annual Report (ASX, ~late September 2026) and the 28 October 2026 quarterly.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Background | Age |
|---|---|---|---|---|
Robert Stein | Chief Executive Officer | Joined 14 Sep 2026 (transition); CEO from 1 Oct 2026 | Chemical engineer (BSc Chem Eng); MBA, Melbourne Business School; 20+ years in resources; prior roles at BHP, MMG and Macquarie Group (Head of Resources Research) | — |
David Oliver Paterson | Founder; former MD & CEO (retired 30 Sep 2026); retained as consultant per Kalkine | Director since 2002; CEO since 2005 | Founding partner of the Latrobe Magnesium project | 68 (Investing.com) |
Ronan Gillen | Chief Operating Officer | — | Leads plant operations and commissioning; presents on commercial pathway (FNN) | — |
Peter Mizera | Independent Chairman, Construction & Completions Committee | Appointed 23 Jul 2026 | Experienced mining project developer | — |
John Robert Lee | Company Secretary (also NED) | Since Dec 2010 | Chairs Risk Committee | 75 |
“—” = not publicly disclosed.
Board of Directors
| Name | Role | Appointed | Independence | Notes |
|---|---|---|---|---|
John (Jock) Stephen Murray | Non-Executive Chairman | 10 Apr 2015 | Independent | Former board member of Terminals Australia (5 years) |
Philip Francis Bruce | Non-Executive Director | 4 Sep 2003 | Independent (per Investing.com) despite 23-year tenure | Director of P F Bruce & Associates (corporate/project management) |
John Robert Lee | Non-Executive Director & Company Secretary | 10 Dec 2010 | Not independent in conventional sense (dual role) | Chairs Risk Committee |
Peter Campbell Church | Non-Executive Director | 2023 (Investing.com) | Not confirmed | — |
Michelle Leanne Blackburn | Non-Executive Director | 2022 (Investing.com) | Not confirmed | — |
David Paterson | Executive Director (until retirement) | 2002 | Executive | Board status after 30 Sep 2026 not confirmed |
Directors' Remuneration
| Executive | Salary | Bonus | Equity | Total | Year |
|---|---|---|---|---|---|
David Paterson (CEO) | A$557K (100% salary) | A$0 | — | A$557K | Latest reported (Simply Wall St; likely FY2025) |
Robert Stein (CEO) | Material terms released under ASX Listing Rule 3.16.4 (23 Jul 2026); figures not captured in sources reviewed | — | Incentives disclosed (details n/d) | — | FY2027 |
Directors (aggregate) | A$80K paid to directors for services in the Dec-2025 quarter (Appendix 5B) | — | — | — | Q2 FY2026 |
“—” = not publicly disclosed.
Major Shareholders
| Holder | Shares | % | Date / source |
|---|---|---|---|
Rimotran Pty Limited (associated with D. Paterson per Simply Wall St) | 179,999,399 | 5.76 | 27 Nov 2025 (Market Index) |
David Oliver Paterson (direct) | 40,415,079 | 1.54 | 17 Sep 2025 (Market Index) |
David Paterson (total relevant interest incl. indirect) | ~180.0M (69.4M direct + 110.6M indirect) | ~5.8 | 27 Nov 2025 |
Jock Murray (indirect) | 25,259,297 | ~0.8 | 27 Nov 2025 |
Philip Bruce | ~17.98M (0.70M direct + 17.27M indirect) | ~0.6 | 27 Nov 2025 |
John Lee | ~13.41M (5.19M direct + 8.22M indirect) | ~0.4 | 27 Nov 2025 |
Long State Investment Ltd | Selling down remaining shares after swap settlement (Sep 2026) | — | ShareCafe |
Competitive Landscape
Key Competitors
| Competitor | Country | Type | Relative positioning vs LMG |
|---|---|---|---|
Chinese Pidgeon-process producers (Shaanxi Fugu/Yulin cluster) | China | Primary producers | Dominant (>90% of world supply); lowest cost; FOB ~US$2,300–2,800/t; high CO2; exposed to US anti-dumping duties |
Baowu Magnesium (formerly Nanjing Yunhai Special Metals; SZSE-listed) | China | Integrated Mg/alloy producer | — |
US Magnesium LLC | USA | Former primary producer (electrolytic, Utah) | Production halted since Sep 2021; Chapter 11 since Sep 2025; ~US$40M needed to restart per testimony |
Magrathea Metals | USA | Start-up (electrolytic from seawater/brine) | Emerging US competitor for the same strategic/defence demand |
MagPro | USA | Primary/alloy producer | Cited as an alternative US producer; small scale |
RIMA Industrial | Brazil | Primary producer (silicothermic) | Established Western-hemisphere producer; limited volume |
Dead Sea Magnesium (ICL) | Israel | Electrolytic producer | Historic Western supplier; operating status should be verified |
Alliance Magnesium | Canada | Developer (from serpentine/asbestos tailings) | Direct waste-to-Mg peer in North America |
Russian producers (e.g., VSMPO-AVISMA, Solikamsk) | Russia | Primary producers | ~6% of global supply; sanctions-constrained in Western markets |
Kazakh producer (UKTMP) | Kazakhstan | Titanium-magnesium complex | Niche primary supply |
Secondary (recycled) Mg producers | Global | Recyclers | Compete for die-cast alloy demand, not primary |
Peer Comparison FY2026
| Metric | LMG (FY2026) | Chinese Pidgeon producers (aggregate) | US Magnesium | Magrathea Metals |
|---|---|---|---|---|
Revenue | A$1.67M reported income (no material sales) | — | Nil production since 2021 (revenue n/d) | Pre-revenue (private) |
Production | Demo; first metal targeted late 2026 | ~1Mtpa global scale (approx.) | Idle | Pilot |
Growth | n/m | — | Negative (bankruptcy) | — |
Margins | Negative | Cost-advantaged; price-taker | — | — |
R&D intensity | High (most spend R&D-eligible) | Low | — | High |
Recent Developments
Litigation/regulatory: * two EPA Victoria infringement notices (January 2025). Layoffs or restructurings are not disclosed.



